ONC · Healthcare · $38.3B
After-hours $358.770.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Float 1.6% · biweekly · settled 26.05.15
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출 17억 달러로 전년 대비 30% 성장했고, 직전 분기 15억 달러에서 뚜렷하게 가속됐어요.”
In the company's words · 2026 2분기 earnings call